GSCHWIND; Andreas
Patent Applications and Registrations
Patent applications and USPTO patent grants for GSCHWIND; Andreas.The latest application filed is for "bispecific binding molecules binding to vegf and ang2".
- GSCHWIND; Andreas - Ingelheim am Rhein DE
- Gschwind; Andreas - Vienna AT
- GSCHWIND; Andreas - Wein AT
- Gschwind; Andreas - Munich N/A DE
- GSCHWIND; Andreas - Wien AT
- Gschwind; Andreas - Unteropfingen DE
- Gschwind; Andreas - Muenchen DE
- Gschwind; Andreas - Munchen DE
- Gschwind, Andreas - Muenich DE
| Patent | Date |
|---|---|
| Bispecific binding molecules binding to VEGF and Ang2 App 20220017642 - GSCHWIND; Andreas ; et al. | 2022-01-20 |
| Bispecific binding molecules binding to VEGF and Ang2 Grant 11,161,916 - Gschwind , et al. November 2, 2 | 2021-11-02 |
| Vegf-binding Molecules App 20200308267 - GSCHWIND; Andreas ; et al. | 2020-10-01 |
| Ang2-binding Molecules App 20200207845 - Ott; Rene Georg ; et al. | 2020-07-02 |
| Bispecific Binding Molecules Binding To Vegf And Ang2 App 20200010569 - GSCHWIND; Andreas ; et al. | 2020-01-09 |
| Bispecific binding molecules binding to VEGF and Ang2 Grant 10,414,828 - Gschwind , et al. Sept | 2019-09-17 |
| Ang2-binding Molecules App 20190135907 - Ott; Rene Georg ; et al. | 2019-05-09 |
| Vegf-binding Molecules App 20180201671 - GSCHWIND; Andreas ; et al. | 2018-07-19 |
| Bispecific Binding Molecules Binding To Vegf And Ang2 App 20170247475 - GSCHWIND; Andreas ; et al. | 2017-08-31 |
| Ang2-binding Molecules App 20170107281 - OTT; Rene Georg ; et al. | 2017-04-20 |
| Bispecific binding molecules binding to VEGF and ANG2 Grant 9,527,925 - Gschwind , et al. December 27, 2 | 2016-12-27 |
| Vegf-binding Molecules App 20160200806 - GSCHWIND; Andreas ; et al. | 2016-07-14 |
| Bispecific Binding Molecules For Anti-angiogenesis Therapy App 20140120095 - BORGES; Eric ; et al. | 2014-05-01 |
| Pharmaceutical Combinations Comprising Dual Angiopoietin-2 / Dll4 Binders And Anti-vegf Agents App 20140093499 - GSCHWIND; Andreas ; et al. | 2014-04-03 |
| Pharmaceutical Combinations Comprising Dual Angiopoietin-2 / Dll4 Binders And Anti-vegf-r Agents App 20140093498 - GSCHWIND; Andreas ; et al. | 2014-04-03 |
| Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation Grant 8,591,903 - Ullrich , et al. November 26, 2 | 2013-11-26 |
| Ang2-binding Molecules App 20130259859 - OTT; Rene Georg ; et al. | 2013-10-03 |
| Unwinder App 20130193254 - Capriotti; Luciano ; et al. | 2013-08-01 |
| Bispecific Binding Molecules Binding To Vegf And Ang2 App 20130078248 - GSCHWIND; Andreas ; et al. | 2013-03-28 |
| Bispecific Binding Molecules Binding To Dii4 And Ang2 App 20130078247 - GSCHWIND; Andreas ; et al. | 2013-03-28 |
| Vegf-binding Molecules App 20120225081 - GSCHWIND; Andreas ; et al. | 2012-09-06 |
| Dll4-binging Molecules App 20110195494 - BORGES; Eric ; et al. | 2011-08-11 |
| Bispecific Binding Molecules For Anti-angiogenesis Therapy App 20110172398 - BORGES; Eric ; et al. | 2011-07-14 |
| Inhibition of TACE or amphiregulin for the Modulation of EGF Receptor Signal Transactivation App 20090292007 - Ullrich; Axel ; et al. | 2009-11-26 |
| Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation Grant 7,524,495 - Ullrich , et al. April 28, 2 | 2009-04-28 |
| Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation App 20060246448 - Ullrich; Axel ; et al. | 2006-11-02 |
| Use of egfr transactivation inhibitors in human cancer App 20050176633 - Ullrich, Axel ; et al. | 2005-08-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 